"There’s an argument that someone of our size and global reach should be larger, generally in private equity," Ares Management CEO Michael Arougheti says during a discussion with Bloomberg's Dani Burger at Bloomberg Invest. (Source: Bloomberg)

Investors eyeing a purchase of 10x Genomics Inc (Symbol: TXG) stock, but cautious about paying the going market price of $22.36/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $15 strike, which has a bid at the time of this writing of $1.45. Collecting that bid as the premium represents a 9.7% return against the $15 commitment, or a 20.6% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to TXG's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $15 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless 10x Genomics Inc sees its shares fall 32.1% and the contract is exercised (resulting in a cost basis of $13.55 per share before broker commissions, subtracting the $1.45 from $15), the only upside to the put seller is from collecting that premium for the 20.6% annualized rate of return. Below is a chart showing the trailing twelve month trading history for 10x Genomics Inc, and highlighting in green where the $15 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the August put at the $15 strike for the 20.6% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for 10x Genomics Inc (considering the last 251 trading day closing values as well as today's price of $22.36) to be 70%. For other put options contract ideas at the various different available expirations, visit the TX...

Investors considering a purchase of SailPoint Inc (Symbol: SAIL) shares, but tentative about paying the going market price of $14.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $10 strike, which has a bid at the time of this writing of $1.00. Collecting that bid as the premium represents a 10% return against the $10 commitment, or a 18.4% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to SAIL's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $10 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless SailPoint Inc sees its shares decline 28.5% and the contract is exercised (resulting in a cost basis of $9.00 per share before broker commissions, subtracting the $1.00 from $10), the only upside to the put seller is from collecting that premium for the 18.4% annualized rate of return. Below is a chart showing the trailing twelve month trading history for SailPoint Inc, and highlighting in green where the $10 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the September put at the $10 strike for the 18.4% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for SailPoint Inc (considering the last 251 trading day closing values as well as today's price of $14.02) to be 56%. For other put options contract ideas at the various different available expirations, visit th...

Audible is rolling out a cheaper “Standard” subscription plan that costs $8.99 per month, the Amazon-owned company announced on Tuesday. The new plan is $6 cheaper than the platform’s existing “Premium” plan, which costs $14.95 per month. The Standard plan includes one audiobook per month from Audible’s catalog and unlimited listening from a curated library that includes a selection of Audible Originals. Under the new Standard plan, subscribers will lose access to the audiobooks they’ve consumed when they unsubscribe. The Premium plan lets users keep the audiobooks they’ve listened to even if they unsubscribe. The Standard plan also includes access to nearly 200 of the most popular titles available on the Wondery+ app, which is shutting down in the coming months. The Standard plan is launching in the United States, the United Kingdom, Canada, Australia, Germany, and France. Audible is testing the plan in additional markets, the company says. The launch of the new subscription plans comes as Audible is facing growing competition from Spotify, which launched audiobooks in 2022 and has bundled the format with music and podcasts as part of its own Premium subscription. Spotify said last October that the number of users listening to audiobooks rose 36% over the past year, and listening hours increased 37%. Additionally, it noted that more than half of Spotify’s 281 million premium subscribers have engaged with an audiobook. Techcrunch event Disrupt 2026: The tech ecosystem, all in one room Your next round. Your next hire. Your next breakout opportunity. Find it at TechCrunch Disrupt 2026, where 10,000+ founders, investors, and tech leaders gather for three days of 250+ tactical sessions, powerful introductions, and market-defining innovation. Register now to save up to $400. Save up to $300 or 30% to TechCrunch Founder Summit 1,000+ founders and investors come together at TechCrunch Founder Summit 2026 for a full day focused on growth, execution, and real-world scaling. ...

Audible is rolling out a cheaper “Standard” subscription plan that costs $8.99 per month, the Amazon-owned company announced on Tuesday. The new plan is $6 cheaper than the platform’s existing “Premium” plan, which costs $14.95 per month. The Standard plan includes one audiobook per month from Audible’s catalog and unlimited listening from a curated library that includes a selection of Audible Originals. Under the new Standard plan, subscribers will lose access to the audiobooks they’ve consumed when they unsubscribe. The Premium plan lets users keep the audiobooks they’ve listened to even if they unsubscribe. The Standard plan also includes access to nearly 200 of the most popular titles available on the Wondery+ app, which is shutting down in the coming months. The Standard plan is launching in the United States, the United Kingdom, Canada, Australia, Germany, and France. Audible is testing the plan in additional markets, the company says. The launch of the new subscription plans comes as Audible is facing growing competition from Spotify, which launched audiobooks in 2022 and has bundled the format with music and podcasts as part of its own Premium subscription. Spotify said last October that the number of users listening to audiobooks rose 36% over the past year, and listening hours increased 37%. Additionally, it noted that more than half of Spotify’s 281 million premium subscribers have engaged with an audiobook. Spotify recently hiked the price of its monthly subscription plan for the third time in three years, potentially opening the door to competitors like Audible. “By expanding our membership options, we’re maximizing access for lighter listeners while enabling publishers and creators to reach new audiences—a win-win that grows the entire audiobook category,” said Cynthia Chu, Chief Financial & Growth Officer at Audible, in a press release. Audible says early testing of the new plan showed strong member acquisition and retention rates, as testing in the U...

Investors eyeing a purchase of Kymera Therapeutics Inc (Symbol: KYMR) shares, but cautious about paying the going market price of $87.93/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $60 strike, which has a bid at the time of this writing of $7.20. Collecting that bid as the premium represents a 12% return against the $60 commitment, or a 15.1% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to KYMR's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $60 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Kymera Therapeutics Inc sees its shares decline 31.3% and the contract is exercised (resulting in a cost basis of $52.80 per share before broker commissions, subtracting the $7.20 from $60), the only upside to the put seller is from collecting that premium for the 15.1% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Kymera Therapeutics Inc, and highlighting in green where the $60 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the December put at the $60 strike for the 15.1% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Kymera Therapeutics Inc (considering the last 251 trading day closing values as well as today's price of $87.93) to be 74%. For other put options contract ideas at the various differen...

Investors considering a purchase of AnaptysBio Inc (Symbol: ANAB) stock, but cautious about paying the going market price of $53.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $35 strike, which has a bid at the time of this writing of $2.60. Collecting that bid as the premium represents a 7.4% return against the $35 commitment, or a 15.9% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to ANAB's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $35 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless AnaptysBio Inc sees its shares fall 35.1% and the contract is exercised (resulting in a cost basis of $32.40 per share before broker commissions, subtracting the $2.60 from $35), the only upside to the put seller is from collecting that premium for the 15.9% annualized rate of return. Below is a chart showing the trailing twelve month trading history for AnaptysBio Inc, and highlighting in green where the $35 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the August put at the $35 strike for the 15.9% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for AnaptysBio Inc (considering the last 251 trading day closing values as well as today's price of $53.97) to be 64%. For other put options contract ideas at the various different available expirations, visit the ANA...

Investors eyeing a purchase of Olaplex Holdings Inc (Symbol: OLPX) shares, but cautious about paying the going market price of $1.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April put at the $1 strike, which has a bid at the time of this writing of 5 cents. Collecting that bid as the premium represents a 5% return against the $1 commitment, or a 40.6% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to OLPX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $1 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Olaplex Holdings Inc sees its shares fall 33.8% and the contract is exercised (resulting in a cost basis of $0.95 per share before broker commissions, subtracting the 5 cents from $1), the only upside to the put seller is from collecting that premium for the 40.6% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Olaplex Holdings Inc, and highlighting in green where the $1 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the April put at the $1 strike for the 40.6% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Olaplex Holdings Inc (considering the last 251 trading day closing values as well as today's price of $1.52) to be 66%. For other put options contract ideas at the various different available expirations, vi...

Investors considering a purchase of AutoZone, Inc. (Symbol: AZO) stock, but cautious about paying the going market price of $3628.30/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2027 put at the $3300 strike, which has a bid at the time of this writing of $240.00. Collecting that bid as the premium represents a 7.3% return against the $3300 commitment, or a 7% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to AZO's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $3300 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless AutoZone, Inc. sees its shares fall 8.4% and the contract is exercised (resulting in a cost basis of $3060.00 per share before broker commissions, subtracting the $240.00 from $3300), the only upside to the put seller is from collecting that premium for the 7% annualized rate of return. Below is a chart showing the trailing twelve month trading history for AutoZone, Inc., and highlighting in green where the $3300 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the March 2027 put at the $3300 strike for the 7% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for AutoZone, Inc. (considering the last 251 trading day closing values as well as today's price of $3628.30) to be 26%. For other put options contract ideas at the various different available expirati...

A man has been convicted of killing his wife after she took her own life following a campaign of domestic abuse, in what is the first prosecution of its kind in Scotland. Kimberly Milne, 28, died after jumping from a motorway bridge in July 2023. Her husband Lee Milne, 39, from Dundee, had denied culpable homicide and a separate charge of domestic abuse, but was found guilty following a trial. The high court in Glasgow heard from prosecutors that the couple had got together in late 2021, and Milne had abused Kimberly from soon into the relationship until the day she died. The couple had married in 2022, and the court heard Kimberly had suffered significant domestic abuse in the 18 months leading up to her death. Milne was also convicted of engaging in a course of abusive conduct towards his wife. Before her death, Kimberly had spoken to police about in incident in 2022 in which Milne choked her, the court heard. “Lee and I were in his home and he went through my phone,” she had told officers. “He saw messages from other men before we were together. He got angry and started to shout and swear at me.” She said he had also called her offensive names, and added: “Immediately after this he put both hands around my neck and pinned me against the kitchen wall. “After a while he swapped his hands, pressed his right forearm against my neck. “A few seconds passed and he let go and started crying, saying how sorry he was.” In another incident, in late 2022, Kimberly told police: “Lee repeatedly punched my ribs and I was begging him not to hurt me but he was not listening. “I felt unsafe so I decided not to leave that night. I slept with a knife under my pillow as I was so frightened of him.” The court heard that on one occasion, Milne pulled Kimberly to the ground by her hair, later apologising and claiming he was “not that type of guy”. Milne had argued he was not responsible for Kimberly’s death, which he said was “a terrible loss” but said she had long-standing mental healt...

Amy Vaillancourt at Voya Financial says most clients "stay the course" during volatile times. She speaks on "Bloomberg Open Interest" at Bloomberg Invest in New York. (Source: Bloomberg)

格隆汇3月4日｜据央视，当地时间3月3日，伊朗军方宣布，过去24小时内，伊朗联合防空司令部的防空系统在伊斯法罕、大不里士、德黑兰周边等多地共击落6架“赫尔墨斯”无人机。声明还指出，自本轮冲突开始以来，伊朗陆军防空部队、空军战机以及伊斯兰革命卫队已累计击落35架美以先进无人机。

Apollo Global Management CEO, Marc Rowan, discusses the scaling of private markets and how the firm is evolving its business to remain competitive with Bloomberg’s John Micklethwait at Bloomberg Invest 2026 in New York. (Source: Bloomberg)

Investors eyeing a purchase of Teledyne Technologies Inc (Symbol: TDY) stock, but cautious about paying the going market price of $678.63/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $610 strike, which has a bid at the time of this writing of $30.10. Collecting that bid as the premium represents a 4.9% return against the $610 commitment, or a 6.9% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to TDY's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $610 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Teledyne Technologies Inc sees its shares fall 9.5% and the contract is exercised (resulting in a cost basis of $579.90 per share before broker commissions, subtracting the $30.10 from $610), the only upside to the put seller is from collecting that premium for the 6.9% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Teledyne Technologies Inc, and highlighting in green where the $610 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the November put at the $610 strike for the 6.9% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Teledyne Technologies Inc (considering the last 251 trading day closing values as well as today's price of $678.63) to be 25%. For other put options contract ideas at the variou...

We're making more two trades. We are exiting our position in BlackRock , selling 35 shares at roughly $1,050 each. In addition, we are buying 90 shares of Cardinal Health at roughly $224 each, increasing its share count in the portfolio to 260 and weighting in the portfolio to 1.5% from 1%. These moves are helping us reposition the portfolio with a more defensive tilt, while preserving our sizable cash position. We added to our Alphabet position early Tuesday. Now, we're swapping out the rest of our BlackRock position, making our second sale in as many days, to buy more Cardinal Health. The net result of these three trades will be neutral to our cash position and return us to slightly over a 15% weighting in the portfolio. As discussed in Monday's trade alert, we're moving on from our BlackRock position because of pressure on the private markets industry. While pressure has been mounting for months, peer Blackstone allowing investors to redeem a record 7.9% of shares from its private credit fund is the latest sign of distress. (Blackstone is a different company and trades under the ticker symbol BX.) BlackRock's private markets business is not its primary fee driver. But we had owned it on the belief that private markets would become more mainstream among retail investors and increasingly find their way into 401(k) plans. Recent weakness across the industry could create resistance to that broader adoption. From Tuesday's exit, we will realize an average gain of about 7% on stock purchased between February and April 2025. We're taking a portion of our BlackRock cash proceeds to add to our newest name , Cardinal Health. We view the broader market pullback as an opportunity to buy more of this drug distributor and medical supplies provider that generates nearly all its revenue inside the United States. With the market increasingly concerned about a potential inflation spike driven by rising energy prices, we're adding to this defensive, economically resilient health-ca...

Investors considering a purchase of Berkshire Hathaway Inc New (Symbol: BRK.B) shares, but tentative about paying the going market price of $479.06/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December 2028 put at the $380 strike, which has a bid at the time of this writing of $18.50. Collecting that bid as the premium represents a 4.9% return against the $380 commitment, or a 1.8% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to BRK.B's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $380 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Berkshire Hathaway Inc New sees its shares decline 20.6% and the contract is exercised (resulting in a cost basis of $361.50 per share before broker commissions, subtracting the $18.50 from $380), the only upside to the put seller is from collecting that premium for the 1.8% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Berkshire Hathaway Inc New, and highlighting in green where the $380 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the December 2028 put at the $380 strike for the 1.8% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Berkshire Hathaway Inc New (considering the last 251 trading day closing values as well as today's price of $479.06) to be 18%. For other put options...

Investors eyeing a purchase of Surgery Partners Inc (Symbol: SGRY) stock, but cautious about paying the going market price of $12.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April put at the $7.50 strike, which has a bid at the time of this writing of 45 cents. Collecting that bid as the premium represents a 6% return against the $7.50 commitment, or a 48.7% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to SGRY's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $7.50 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Surgery Partners Inc sees its shares decline 41.4% and the contract is exercised (resulting in a cost basis of $7.05 per share before broker commissions, subtracting the 45 cents from $7.50), the only upside to the put seller is from collecting that premium for the 48.7% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Surgery Partners Inc, and highlighting in green where the $7.50 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the April put at the $7.50 strike for the 48.7% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Surgery Partners Inc (considering the last 251 trading day closing values as well as today's price of $12.87) to be 52%. For other put options contract ideas at the various different a...

Kuehne & Nagel International press release ( KHNGF ): FY GAAP EPS of CHF7.42. Revenue of CHF24.47M. More on Kuehne + Nagel International AG Seeking Alpha’s Quant Rating on Kuehne + Nagel International AG Historical earnings data for Kuehne + Nagel International AG Dividend scorecard for Kuehne + Nagel International AG Financial information for Kuehne + Nagel International AG

【有線新聞】中東局勢緊張，入境處連日接獲585名身在當地港人查詢，包括最新航班及行程安排。迪拜有限度復飛，有滯留港人隨即向阿聯酋航空訂機票，在不保證機位下但求買一個希望，亦有人在社交平台說獲建議取道鄰國阿曼返港。 迪拜機場宣布有限度復飛後，阿聯酋航空有航班成功離境。滯留迪拜港人阿順原定3月9日國泰返港航班都已取消，於是向阿聯酋航空補買3月5日機票，買一個回港希望。阿順：「我的航班本來48小時內起飛，嘗試於網上做預辦登機手續時稱該班機不能預辦登機。根據最新政策，會先照顧先前購票的顧客，通知暫時不要前往機場，待航空公司通知有機位才前往機場。買完那張機票後，數小時後再查看，已升了好幾百元，見到有搶購情況。但搶購完後可以買了、扣錢了，出機票後都不一定保證到機位，等他派機位，等他讓我預辦登機。可能到機場博一博，若入不到機場又打回頭，即心情很複雜很傍偟，亦很絕望。」 社交平台有不少滯留港人都希望把握機場復飛機會離港。除了機票再三被取消，亦有滯留港人在社交網站發文稱由朋友代為向入境處查詢，獲建議在安全情況下取道阿曼回港。阿順：「知有其他港人陸逐考慮其他選項，例如去旁邊的阿曼馬斯喀特。暫時入境處給我的資訊都是上網見到資訊，就是類似哪個機場有復飛跡象、哪間航空公司有航班復飛，暫時都是已知資訊。入境處未有其他建議，反而都是留在安全地方。」 他說目前迪拜未有明確出路，但仍然相對安全，亦保證食宿，又擔心改道阿曼會有很多不確定性，所以難以作出決定。

格隆汇3月4日｜谷歌：推出Gemini 3.1 Flash-Lite，我们速度最快、性价比最高的Gemini 3系列模型。

Key Points Sector tailwinds were one factor in boosting FedEx shares last month. The stock is one of the top five holdings in two large transportations ETFs. FedEx has four strategic priorities to meet 2029 financial goals. 10 stocks we like better than FedEx › FedEx (NYSE: FDX) shareholders have had a good last year. The stock has rocketed nearly 50% higher over the past 12 months. Much of that came just last month, though. There were both sector and company-specific reasons for the February move. FedEx stock jumped 20.1% last month alone, according to data provided by S&P Global Market Intelligence. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Sector tailwinds As investors shift their focus from technology stocks to industrials, names like FedEx benefit. The global courier delivery company's stock was among the top five holdings of two leading transportation sector exchange-traded funds (ETFs) as of February 2026. The ETFs, iShares U.S. Transportation ETF and SPDR S&P Transportation ETF, hold about $1.5 billion in combined assets under management. Last month marked a period when investors began to sour on big tech names amid fears of overspending on artificial intelligence (AI) infrastructure. Investors moved money into FedEx as the company sought to recoup tariff-related costs after the Supreme Court ruled some of President Trump's tariffs were illegally implemented. FedEx was among thousands of companies petitioning the U.S. Court of International Trade in Manhattan for tariff refunds levied by President Donald Trump last year, according to Reuters. FedEx has a plan Another thing impacting FedEx stock last month was its Investor Day presentation held on Feb. 12. The company is focusing on achieving premium growth in high-margin sectors, enhancing its digital and AI capabilities, and continu...

FedEx (FDX 2.09%) shareholders have had a good last year. The stock has rocketed nearly 50% higher over the past 12 months. Much of that came just last month, though. There were both sector and company-specific reasons for the February move. FedEx stock jumped 20.1% last month alone, according to data provided by S&P Global Market Intelligence. Sector tailwinds As investors shift their focus from technology stocks to industrials, names like FedEx benefit. The global courier delivery company's stock was among the top five holdings of two leading transportation sector exchange-traded funds (ETFs) as of February 2026. The ETFs, iShares U.S. Transportation ETF and SPDR S&P Transportation ETF, hold about $1.5 billion in combined assets under management. Last month marked a period when investors began to sour on big tech names amid fears of overspending on artificial intelligence (AI) infrastructure. Investors moved money into FedEx as the company sought to recoup tariff-related costs after the Supreme Court ruled some of President Trump's tariffs were illegally implemented. FedEx was among thousands of companies petitioning the U.S. Court of International Trade in Manhattan for tariff refunds levied by President Donald Trump last year, according to Reuters. Expand NYSE : FDX FedEx Today's Change ( -2.09 %) $ -8.10 Current Price $ 379.15 Key Data Points Market Cap $91B Day's Range $ 374.45 - $ 383.00 52wk Range $ 194.29 - $ 392.86 Volume 30K Avg Vol 1.9M Gross Margin 22.05 % Dividend Yield 1.48 % FedEx has a plan Another thing impacting FedEx stock last month was its Investor Day presentation held on Feb. 12. The company is focusing on achieving premium growth in high-margin sectors, enhancing its digital and AI capabilities, and continuing to transform its network, aiming to significantly boost profits and create value for shareholders. FedEx CEO Raj Subramaniam summed up his vision this way: FedEx is now entering a new era as we build the most flexible, efficient, and i...

1 The Distribution Rate shown is based on the NAV per share as of March 2 , 202 6 , adjusted for corporate actions. T he Distribution Rate is the annual rate an investor would receive if the most recent distribution remained the same going forward. The rate represents a single distribution from the fund and does not represent total return to the fund. The distribution rate is calculated by annualizing the most recent distribution and dividing it by the most recent NAV adjusted for corporate actions. 2 The 30-Day SEC Yield represents the net investment income (excluding option income) earned by the ETF over the 30-day period ended January 31 , 202 6 . It is expressed as an annualized percentage rate based on the ETF ’ s share price at the end of that period. 3 Each GraniteShares Autocallab l e ETF seeks to generate potential monthly income by investing in a portfolio of single-stock autocallable options linked to the performance of its reference equity (such as Nvidia). The Fund may distribute income, where available, and will manage positions through a laddered approach and ongoing rolling. Distributions may vary and are not guaranteed, and the Fund remains subject to equity-linked downside risk. 4 ROC or Return of Capital indicates how much the distribution reflects an investor's initial investment and are determined in accordance with generally accepted accounting principles (“GAAP”) . The timing and character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. As such, t he figures shown for each Fund in the table above are estimates based on the latest 19a1 forms and may later be determined to be taxable net investment income, short-term gains, long-term gains (to the extent permitted by law), or return of capital. Actual amounts and sources for tax reporting will depend upon the Fund's investment activities during the remainder of the fiscal year and may be subject to changes base...

Arcola theatre, London Nicolas Kent directs a set of short plays by British and Ukrainian writers giving devastating vignettes from the conflict Nicolas Kent’s concept for a series of short plays on the war in Ukraine is based on his 2009 cycle of dramas about the colonial history of Afghanistan , similarly staged while war raged. A smaller enterprise, with five rather than 12 plays, Ukraine Unbroken packs a punch, rising in both power and horror over the course of the evening. The opening two are more explanatory and historical, shooting an arrow through the fog of the Russian invasion of 2022 and the subsequent war to lay bare earlier violations. Always, written by Jonathan Myerson, features a politician (David Michaels) and his wife (Sally Giles), trapped in a hotel room as snipers shoot outside at a crowd in Kyiv and captures the history of protest in the Maidan Uprising of 2013-14 . David Edgar’s Five Day War dramatises deadly Russian colonial ambition and features preparations for Russian victory with mock press conferences played out, including one imagining President Zelenskyy’s death. It is informative and original in form though harder to connect with than the subsequent plays. At Arcola theatre, London , until 28 March Continue reading...

Apple Inc. Unveils New Studio Display and All-New Studio Display XDR marketscreener.com

Investors eyeing a purchase of Fiserv Inc (Symbol: FISV) stock, but tentative about paying the going market price of $61.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2028 put at the $35 strike, which has a bid at the time of this writing of $2.60. Collecting that bid as the premium represents a 7.4% return against the $35 commitment, or a 3.9% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to FISV's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $35 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Fiserv Inc sees its shares decline 42.3% and the contract is exercised (resulting in a cost basis of $32.40 per share before broker commissions, subtracting the $2.60 from $35), the only upside to the put seller is from collecting that premium for the 3.9% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Fiserv Inc, and highlighting in green where the $35 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the January 2028 put at the $35 strike for the 3.9% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Fiserv Inc (considering the last 250 trading day closing values as well as today's price of $61.10) to be 72%. For other put options contract ideas at the various different available expirations, visit the FISV Stock ...

J.P. Morgan maintained an overweight rating and a $20 price target for Riot (NASDAQ: RIOT), despite the miner posting a 15% sequential decline in fourth-quarter revenue to $157 million, according to a Tuesday research note from the bank. The $20 target price is anchored by Riot’s 1.7-gigawatt portfolio across its Rockdale and Corsicana sites in Texas. J.P. Morgan said these sites should see strong interest from neocloud and hyperscaler providers since they are tier-one market locations for AI workloads. The #1 podcast for emerging tech stocks, Bitcoin, and weekly news analysis. Subscribe to the Blockspace Podcast here, on Apple, Spotify, or anywhere you listen to podcasts. Riot’s recent AMD agreement adds a premium to J.P. Morgan’s valuation. Riot energized the first 5 megawatts of critical infrastructure just one month after signing the contract, with the remaining 20 megawatts on track for delivery in May 2026. If Riot and AMD exercise options to extend the deal, Riot could net $1 billion from the partnership. Riot’s team is currently marketing further capacity at its 700 MW Rockdale facility and 1,000 MW Corsicana site to prospective AI/HPC tenants, the note claims. Analysts Reginald L. Smith and Charles Pearce highlighted the negotiating leverage held by the infrastructure provider as a catalyst for future revenue. Institutional support also bolsters the valuation, with Fidelity Investments taking an 8% stake in November 2025 and activist investor Starboard Value projecting the stock could reach $52.60 if the AI infrastructure pivot succeeds. Conversely, surging production costs act as J.P. Morgan’s primary ding against Riot in its valuation model. J.P. Morgan estimates that Riot’s total production cost per bitcoin mined surged 34% sequentially to $97,200 during the fourth quarter. Direct power costs hit $60,600 per coin, representing a 31% sequential increase that cut into Riot’s profitability margins. Cash-modified earnings dropped to $13 million, falling shor...

Investors considering a purchase of Corplay Inc (Symbol: CPAY) shares, but cautious about paying the going market price of $327.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2027 put at the $250 strike, which has a bid at the time of this writing of $7.00. Collecting that bid as the premium represents a 2.8% return against the $250 commitment, or a 3.2% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to CPAY's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $250 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Corplay Inc sees its shares fall 22.9% and the contract is exercised (resulting in a cost basis of $243.00 per share before broker commissions, subtracting the $7.00 from $250), the only upside to the put seller is from collecting that premium for the 3.2% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Corplay Inc, and highlighting in green where the $250 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the January 2027 put at the $250 strike for the 3.2% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Corplay Inc (considering the last 251 trading day closing values as well as today's price of $327.10) to be 41%. For other put options contract ideas at the various different available expirations, visit ...

Stephan Behnes Broad adoption of stablecoins could weaken monetary policy transmission and potentially erode monetary sovereignty, a working paper released by the European Central Bank said on Tuesday. The paper sought to study the effects of stablecoin adoption on bank intermediation and the transmission of monetary policy. Stablecoins are a crypto asset designed to hold a stable value against a reference asset, such as the euro or U.S. dollar. Fast growth of stablecoins could lead to large shifts from retail bank deposits to digital assets, increasing banks' reliance on wholesale funding, thus constraining banks' intermediation capacity, the paper said. That could reduce the amount of credit banks provide to the real economy. "Importantly, these effects are nonlinear and depend critically on the scale of stablecoin adoption, their design features, and their regulatory treatment," the authors wrote in a summary of the paper. For monetary policy, the paper found that in the euro area, banks play a key role in transmitting rate changes to households and firms. The shift of deposits into stablecoins can interfere with multiple monetary policy transmission channels, "potentially weakening the predictability of policy actions," it noted. The paper's third policy-related finding warns that stablecoins linked to non-euro currencies, such as the U.S. dollar, if adopted widely, would increase the risk to monetary policy significantly. "In simple terms, foreign monetary conditions could be 'imported' into the euro area through stablecoins. This would weaken the central bank’s control over financial conditions, reduce the effectiveness of traditional monetary policy instruments, and make it harder to stabilize inflation and economic activity, especially during periods of financial stress," the paper warned. The findings underscore the importance of stronger transparency requirements for stablecoin reserves, robust redemption guarantees, an adequate capital buffer to absorb lo...

Investors eyeing a purchase of Zebra Technologies Corp. (Symbol: ZBRA) stock, but cautious about paying the going market price of $219.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $120 strike, which has a bid at the time of this writing of $1.90. Collecting that bid as the premium represents a 1.6% return against the $120 commitment, or a 2% annualized rate of return (at Stock Options Channel we call this the). Selling a put does not give an investor access to ZBRA's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $120 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Zebra Technologies Corp. sees its shares fall 45.2% and the contract is exercised (resulting in a cost basis of $118.10 per share before broker commissions, subtracting the $1.90 from $120), the only upside to the put seller is from collecting that premium for the 2% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Zebra Technologies Corp., and highlighting in green where the $120 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the December put at the $120 strike for the 2% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Zebra Technologies Corp. (considering the last 251 trading day closing values as well as today's price of $219.78) to be 48%. For other put options contract ideas at the various differe...